Hyosung Chemical stock reports 41.20 percent Q2 revenue growth

Published on 09/30/2026 at 13:50 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Hyosung Chemical stock generated KRW 171.0 billion in Q2 operating profit, compared with a loss in the prior-year quarter. A KRW 81.6 billion guarantee adds risk context.

Hyosung Chem, KR7298000001, Illustration mit AI erstellt.

Hyosung Chemical stock was last at KRW 53,900 on the Korea Exchange on September 30, 2026 at 3:30 a.m. KST, while the company reported a sharp Q2 2026 earnings recovery. Revenue reached KRW 871.0 billion, up 41.20 percent from Q2 2025, and operating profit reached KRW 171.0 billion.

Q2 earnings mark a turnaround

According to ATS View, Hyosung Chemical's Q2 2026 net income was KRW 156.0 billion, compared with KRW 102.0 billion in Q2 2025. The operating margin reached 19.60 percent, a sharp contrast with the 1.50 percent operating loss margin reported for Q2 2025.

The comparison with Q1 2026 is equally important. Revenue increased from KRW 587.0 billion to KRW 871.0 billion, while operating profit rose from KRW 0.3 billion to KRW 171.0 billion, according to ATS View.

Vietnam guarantee adds a risk test

The earnings improvement is accompanied by a fresh financing commitment. DigitalToday reported that Hyosung Chemical approved a KRW 81.6 billion guarantee for Hyosung Vina Chemicals on September 29, 2026, equal to 12.89 percent of equity. The guarantee period runs from September 30, 2026, to August 31, 2027.

The total guarantee balance was KRW 784.97 billion, including unused limits, according to DigitalToday. That figure gives investors a counterweight to the Q2 rebound because subsidiary funding remains a material balance-sheet issue.

KRX valuation remains below yearly high

Hyosung Chemical's KRW 53,900 KRX price on September 30, 2026 sits within a 52-week range of KRW 38,900 to KRW 87,500. The market capitalization was KRW 203.1 billion on the same date, and the company is listed on the Korea Exchange KOSPI market under ticker 298000.

For investors, the central contrast is numerical: quarterly operating profit moved from a KRW 9.0 billion loss in Q2 2025 to KRW 171.0 billion in Q2 2026, while the guarantee balance remains KRW 784.97 billion. The next assessment of Hyosung Chemical stock will depend on whether the Q2 margin improvement extends beyond one reporting period.